Norwegian ParkWest Study
The Norwegian ParkWest study is a prospective population-based longitudinal cohort study of individuals with incident Parkinson’s disease (PD) in Western and Southern Norway. The study area comprises the four counties of Sogn and Fjordane, Hordaland, Rogaland and Aust-Agder. The initial cohort comprised of 212 newly-diagnosed and drug-naïve individuals with suspected PD, who were followed with standardised clinical examinations every 6 months. Control subjects who were free from parkinsonism, dementia, major depression, and psychosis were recruited from friends and spouses of individuals with PD. Of the PD cohort, 41.1% were women, and the average age at baseline was 67.9 years.
Study design
Cohort - clinical
Number of participants at first data collection
205 (controls)
212 (participants)
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
Individuals over the age of 18 years in Norway with newly diagnosed and drug naïve Parkinson's disease.
Sample features
Country
Year of first data collection
2004
Primary Institutions
Stavanger University Hospital
Links
Profile paper DOI
Funders
Norwegian Parkinson's Research Foundation
Rebergs Legacy
Research Council of Norway (Norges forskningsråd)
Western Norway Regional Health Authority
Ongoing?
Yes
Data types collected
- Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- None
- Magnetic Resonance Imaging (MRI)
- None
Engagement
Keywords
